Related Experiment Video
Updated: Oct 10, 2025
10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.4K
Summary
Genomically guided targeted therapy improves outcomes for metastatic breast cancer patients. This approach enhances progression-free survival by targeting specific tumor mutations effectively.
Area of Science:
- Oncology
- Genomics
- Pharmacology
Background:
- Metastatic breast cancer (MBC) presents significant treatment challenges.
- Identifying actionable mutations is crucial for effective therapy selection.
Discussion:
- Genomic profiling of tumors allows for personalized treatment strategies.
- Targeted therapies exploit specific molecular alterations in cancer cells.
Key Insights:
- Genomically guided targeted therapy significantly improves progression-free survival in MBC.
- Tumors with specific, targetable mutations respond well to this precision medicine approach.
Outlook:
- Further research into novel targeted therapies and resistance mechanisms is warranted.
- Wider adoption of genomic testing can optimize treatment paradigms for MBC patients.
Related Concept Videos
02:07Tumor Progression
6.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
01:21Cancer Survival Analysis
478
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
478
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:27Tumor Immunotherapy
723
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
723